Akero Therapeutics Inc. (AKRO) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Akero Therapeutics Inc.

    NASDAQ: AKRO · Real-Time Price · USD
    44.93
    1.68 (3.88%)
    At close: Sep 11, 2025, 3:59 PM
    45.50
    1.27%
    After-hours: Sep 11, 2025, 07:16 PM EDT

    Akero Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -7.41 -8.09 -19.62 -7.31
    PEG Ratio
    		 -0.25 -11.61 28.34 -0.5
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 2.49 2.29 6.54 4.36
    P/FCF Ratio
    		 -8.12 -8.44 -23.09 -9.24
    P/OCF Ratio
    		 -8.12 -8.44 -23.09 -9.24
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.05 0.05 0.03 0.01
    Quick Ratio
    		 19.38 29.27 18.61 7.70
    Current Ratio
    		 19.38 29.27 18.61 7.70
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 -61.14 -55.78 -155.83 n/a
    Return on Equity
    		 -0.34 -0.28 -0.33 -0.6
    Return on Assets
    		 -0.31 -0.26 -0.31 -0.52
    Return on Invested Capital
    		 -0.36 -0.31 -0.33 -0.59
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist